Chestnut Street Ventures

Chestnut Street Ventures is a venture capital firm based in New York, specializing in investments in start-ups and companies at various stages of development. Founded in 2016, the firm focuses on companies led by alumni of the University of Pennsylvania, fostering a community of investors, executives, and entrepreneurs with ties to the university. Chestnut Street Ventures invests across a wide range of industries, with particular emphasis on B2B, B2C, augmented reality/virtual reality, blockchain, data aggregation platforms, enterprise software, and automotive technology. The firm typically invests between $200,000 and $500,000, with opportunities to invest up to $2 million through co-investment programs.

Past deals in Philadelphia, PA

NeuroFlow

Venture Round in 2018
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.

Bainbridge Health

Seed Round in 2018
Bainbridge Health, Inc. is a Philadelphia-based company that develops a clinical intelligence and data analytics platform focused on improving medication safety in hospital systems. Founded in 2016, the company provides solutions specifically for medication safety leaders, including an infusion pump management software known as InfusionWare. This platform allows clinicians to manage infusion data centrally, enhancing patient safety by streamlining data handling and reducing the likelihood of medication errors. Bainbridge Health’s vendor-agnostic approach eliminates the need for cumbersome data management practices, enabling hospitals to mitigate risks associated with medication errors while also lowering avoidable costs.

NeuroFlow

Seed Round in 2017
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.